Agape ATP Corporation (NASDAQ:ATPC – Get Free Report)’s stock price was down 1.6% on Monday . The stock traded as low as $2.41 and last traded at $2.42. Approximately 22,209 shares were traded during trading, a decline of 99% from the average session volume of 2,278,502 shares. The stock had previously closed at $2.46.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research report on Friday, May 22nd. Wall Street Zen upgraded shares of Agape ATP from a “sell” rating to a “hold” rating in a research note on Monday, June 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.
Get Our Latest Report on Agape ATP
Agape ATP Price Performance
Agape ATP (NASDAQ:ATPC – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%. The firm had revenue of $0.27 million for the quarter.
Institutional Trading of Agape ATP
An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC grew its holdings in shares of Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 0.01% of the company’s stock.
About Agape ATP
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Featured Articles
- Five stocks we like better than Agape ATP
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
